Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol

INTRODUCTION: High-risk human papilloma virus (HPV)-associated cervical cancer is the fourth most common cancer in women worldwide. Current treatments of high-grade squamous intraepithelial lesion (HSIL) of the cervix are based on invasive surgical interventions, compromising cervical competence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fei, Novák, Zoltán, Dannecker, Christian, Mokráš, Ctirad, Sui, Long, Zhang, Youzhong, You, Zhixue, Han, Ling, Lang, Jinghe, Hillemanns, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171256/
https://www.ncbi.nlm.nih.gov/pubmed/35667715
http://dx.doi.org/10.1136/bmjopen-2022-061740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171256/
https://www.ncbi.nlm.nih.gov/pubmed/35667715
http://dx.doi.org/10.1136/bmjopen-2022-061740

Ejemplares similares